En español

Associate Director, AIDS Research Program

Revised January 2018


The National Institute on Drug Abuse (NIDA) is recruiting an Associate Director for the AIDS Research Program (ARP). Interested and qualified applicants are encouraged to apply through the NIH vacancy announcement for Health Scientist Administrators that will open from January 29 - February 7, 2018 on USAJobs.gov. The position is a nonsupervisory GS-15.

The Associate Director, ARP, plays a vital role in ensuring the success of the institute’s HIV, AIDS, and addiction research activities.  NIDA has the second largest research portfolio dedicated to understanding and eradicating HIV and successfully treating AIDS.  Many people living with HIV use drugs, and drug abuse contributes to the spread of HIV and complicates the effectiveness of current prevention and treatment interventions.  Addressing HIV is a high scientific priority for NIDA, and this body of work is a third of the institute’s budget. 

The Associate Director works with the Director, ARP, providing leadership in developing and executing activities of the office, serves as the secondary in the Director’s absence, ensuring continuity of addiction and AIDS research activities, and has a unique portfolio of communication, collaboration, and consultation activities.  The Associate Director assists the Director in essential activities including developing scientific vision, strategic management, implementation, and budgetary oversight for the NIDA AIDS portfolio.  This person develops communication materials and manages content for the NIDA website to inform NIDA, other collaborative partners, and the research community about scientific priorities and discoveries from the NIDA portfolio, new initiatives, and emerging scientific opportunities.  The Associate Director, ARP, serves as an AIDS and drug abuse expert for the institute, developing initiatives and authoring funding announcements intended to bringing innovation to the NIH and NIDA AIDS research program.  This position plays a vital role in developing new and managing existing extensive scientific and other collaborative efforts with the NIH Office of AIDS Research, other IC’s, federal agencies, scientific groups and the investigator community, and key stakeholders.  These collaborative endeavors are essential and ensure research is addressing the unique aspects of drug use and intersection with HIV and AIDS, and that NIDA’s research portfolio works synergistically with the scientific investments of other groups in this area.  These scientific partnerships include the National Institute on Aging, National Institute of Allergy and Infectious Diseases, National Institute on Child Health and Human Development, National Institute of Mental Health, the Fogarty International Center, the Center for Disease Control and Prevention, and the World Health Organization, to name a few.

This page was last updated January 2018